We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+15.78%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$13.5B
AUM Growth
+$1.89B
(+16%)
Cap. Flow
+$530M
Cap. Flow
% of AUM
3.93%
Top 10 Holdings %
Top 10 Hldgs %
31.71%
Holding
339
New
59
Increased
111
Reduced
94
Closed
41
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$157M |
| 2 |
Johnson & Johnson
JNJ
|
+$155M |
| 3 |
Chegg
CHGG
|
+$87.6M |
| 4 |
Medtronic
MDT
|
+$72.1M |
| 5 |
Humana
HUM
|
+$69.3M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$133M |
| 2 |
Ciena
CIEN
|
+$99.1M |
| 3 |
Advanced Micro Devices
AMD
|
+$79.2M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
+$73.2M |
| 5 |
AYX
Alteryx Inc
AYX
|
+$70M |
Sector Composition
| 1 | Technology | 35.47% |
| 2 | Healthcare | 19.83% |
| 3 | Financials | 14.52% |
| 4 | Communication Services | 13.91% |
| 5 | Consumer Discretionary | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HGEN
176
DELISTED
HUMANIGEN, INC.
HGEN
| $8.78M | 0.07% |
+825,000
| New | +$8.47M |
|
177
Veeco
VECO
$3.19B
| $8.6M | 0.06% |
737,032
-218,572
| -23% | -$2.79M |
|
|
MRTX
178
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8.3M | 0.06% |
50,000
-35,000
| -41% | -$4.79M |
|
179
Affiliated Managers Group
AMG
$9.77B
| $8.15M | 0.06% |
119,195
-37,659
| -24% | -$2.63M |
|
180
Bank of America
BAC
$430B
| $8.14M | 0.06% |
338,101
-276,983
| -45% | -$6.9M |
|
181
Canadian Natural Resources
CNQ
$91.5B
| $7.79M | 0.06% |
835,288
-31,674
| -4% | -$285K |
|
182
Emerson Electric
EMR
$78.2B
| $7.69M | 0.06% |
117,267
+12,151
| +12% | +$800K |
|
183
Toronto Dominion Bank
TD
$204B
| $7.48M | 0.06% |
135,974
-2,540
| -2% | -$118K |
|
|
CTLT
184
DELISTED
CATALENT, INC.
CTLT
| $7.4M | 0.05% |
+86,345
| New | +$7.3M |
|
185
HCA Healthcare
HCA
$82.3B
| $7.24M | 0.05% |
58,062
-30,500
| -34% | -$3.78M |
|
186
MarketAxess Holdings
MKTX
$4.04B
| $7.16M | 0.05% |
14,872
+7,860
| +112% | +$3.89M |
|
|
BLU
187
DELISTED
BELLUS Health Inc.
BLU
| $6.81M | 0.05% |
3,000,000
+2,250,000
| +300% | +$6.38M |
|
188
Cardiff Oncology
CRDF
$60.2M
| $6.71M | 0.05% |
+472,908
| New | +$3.12M |
|
|
VRNA
189
DELISTED
Verona Pharma
VRNA
| $6.24M | 0.05% |
+1,000,000
| New | +$6.91M |
|
190
JD.com
JD
$40B
| $6.2M | 0.05% |
79,886
+19,532
| +32% | +$1.36M |
|
191
Sabre
SABR
$684M
| $5.93M | 0.04% |
910,783
-455,828
| -33% | -$3.38M |
|
192
Mohawk Industries
MHK
$6.8B
| $5.89M | 0.04% |
60,365
-75,148
| -55% | -$6.76M |
|
193
Cogent Biosciences
COGT
$6.68B
| $5.85M | 0.04% |
+625,000
| New | +$6.52M |
|
194
PNC Financial Services
PNC
$101B
| $5.83M | 0.04% |
53,075
-3,816
| -7% | -$410K |
|
195
CALL
Apple
AAPL
$4.9T
| $5.37M | 0.04% |
46,400
-17,600
| -28% | -$1.92M |
|
196
Blackstone
BX
$155B
| $4.95M | 0.04% |
94,904
-9,045
| -9% | -$484K |
|
197
TSMC
TSM
$2.07T
| $4.9M | 0.04% |
+60,446
| New | +$4.59M |
|
198
Sysco
SYY
$39.1B
| $4.83M | 0.04% |
77,661
-27,705
| -26% | -$1.61M |
|
199
IPG Photonics
IPGP
$4.43B
| $4.66M | 0.03% |
27,403
+12,530
| +84% | +$2.07M |
|
200
Philip Morris
PM
$301B
| $4.65M | 0.03% |
+62,000
| New | +$4.78M |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q3 2020 Portfolio in Review
As of Q3 2020, Polar Capital held 339 positions worth $13.5B, up 16% from $11.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Polar Capital deployed $530M of net new capital in Q3 2020, opening 59 new positions and adding to 111 existing holdings. Its largest new stake was Chegg: 1,189,909 shares worth $85M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was UnitedHealth, an estimated $133M trimmed.
- Polar Capital's largest Q3 2020 buy was Chegg: 1,189,909 shares worth $85M.
- Polar Capital added most to Meta Platforms (Facebook) in Q3 2020, an estimated $157M increase.
- Polar Capital's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $133M.
- Polar Capital fully exited Ciena in Q3 2020, selling an estimated $99.1M.
- Polar Capital's ten largest holdings make up 32% of its $13.5B portfolio in Q3 2020.
- Polar Capital opened 59 new positions and closed 41 in Q3 2020.
- Polar Capital's portfolio value rose 16% quarter-over-quarter to $13.5B.
Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.